Ocean Biomedical Inc OCEA

Healthcare Biotechnology

Ocean Biomedical, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The Company helps to accelerates the development and commercialization of assets from research universities and medical centers. In oncology, it is engaged in developing a mono-specific and two bi-specific humanized monoclonal antibodies (mAb), product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer (NSCLC), and of glioblastoma multiforme (GBM). It offers three product candidates based on the novel target discoveries: a malaria vaccine candidate targeting either or both of PfSEA-1, and parasite antigen PfGARP, which is referred to as its ODA-570 candidate; a humanized mAb malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-611 candidate, and a small molecule malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-579 candidate.

NDAQ:OCEA - Post by User

Ocean Biomedical Inc

<< Previous

Bullboard Posts

Next >>

Post by Iseneschalon Jun 22, 2023 12:08pm

58 Views

Post# 35509349

OCEA....You know this is going higher....

especially after this a.m's retracement to sub $6....added a position just above $6 this a.m ; )

They announced a price target of over $17/sh yesterday...let see if they full of BS or not

Cheers

<< Previous

Bullboard Posts

Next >>

Catch up with companies that got a Stanley Cup Playoffs boost